2-Morpholinoethyl-5,12-dioxo-5,12-dihydroindolizino[2,3-g]phthalazine-11-carboxylate

ID: ALA4176746

PubChem CID: 145972451

Max Phase: Preclinical

Molecular Formula: C21H18N4O5

Molecular Weight: 406.40

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2cnncc2C(=O)c2c1c(C(=O)OCCN1CCOCC1)c1ccccn21

Standard InChI:  InChI=1S/C21H18N4O5/c26-19-13-11-22-23-12-14(13)20(27)18-17(19)16(15-3-1-2-4-25(15)18)21(28)30-10-7-24-5-8-29-9-6-24/h1-4,11-12H,5-10H2

Standard InChI Key:  CGNVQIMMQLXXOR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   17.2477  -30.9749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2477  -31.7920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9530  -32.1965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9530  -30.5621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6582  -30.9749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6548  -31.7920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3568  -32.2013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3638  -30.5670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3661  -29.7498    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3522  -33.0185    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0703  -30.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0689  -31.7977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8477  -30.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3267  -31.3915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8452  -32.0466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1699  -32.7870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9771  -32.8786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4586  -32.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1329  -31.4769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2511  -30.0173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0683  -30.0105    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8366  -29.3131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.4828  -30.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3000  -30.7078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7145  -31.4121    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3084  -32.1174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7194  -32.8196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5370  -32.8170    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.9418  -32.1060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5290  -31.3976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
  7 12  1  0
 11  8  1  0
  8  9  2  0
  7 10  2  0
 11 12  2  0
 12 15  1  0
 14 13  2  0
 13 11  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 13 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4176746

    ---

Associated Targets(Human)

HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Topoisomerase I (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DNA (609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.40Molecular Weight (Monoisotopic): 406.1277AlogP: 0.99#Rotatable Bonds: 4
Polar Surface Area: 103.10Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: 0.08CX LogD: 0.08
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -0.93

References

1. Yu Q, Yang H, Zhu TW, Yu LM, Chen JW, Gu LQ, Huang ZS, An LK..  (2018)  Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors.,  152  [PMID:29705710] [10.1016/j.ejmech.2018.04.040]

Source